The Union Budget 2025 emphasizes agriculture as a key driver of India’s economy, with initiatives aimed at modernisation and ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...

Acres Farms, the vertical farming startup headquartered in Hamilton, announced Monday, Feb. 10, capital raises last year ...

Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Gilead Sciences posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

The next phase of Kilroy's big Oyster Point project is seeing interest from tech and financial services as well as biotech, ...

The company, co-founded by Cleveland Clinic in 2013, had a couple major objectives for the funding: expanding the commercial ...

The formation of living intelligence could "drive a supercycle of exponential growth and disruption across multiple ...

Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price appreciation has been modest.